Lnc-CYP4A22-2/3

From LncRNAWiki
Revision as of 07:57, 5 November 2018 by Huma (talk | contribs) (Created page with " ==Annotation== ===Name=== lnc-CYP4A22-2/3 ===Alias=== NA ===Disease=== Disease: clear cell renal cell cancer [http://www.ncbi.nlm.nih.gov/pubmed/26609485 (PMID:26609485)]...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search


Annotation

Name

lnc-CYP4A22-2/3

Alias

NA

Disease

Disease: clear cell renal cell cancer (PMID:26609485)

Dysfunction type: expression

Description: lnc-ZNF180-2 levels were similar in localized ccRCC and normal renal tissue, but we observed a significant increase of lnc-ZNF180-2 expression in advanced ccRCC tissue. Furthermore, lnc-ZNF180-2 expression levels were an independent predictor of progression-free survival, cancer-specific survival and overall survival in ccRCC patients. We also observed that lnc-CYP4A22-2/3 expression levels allowed discrimination of ccRCC and normal renal tissue. In conclusion, lncRNAs are involved in renal carcinogenesis, and quantification of lnc-ZNF180-2 may be useful for the prediction of ccRCC patients outcome following nephrectomy.


Function

Function Mechanism: NA (PMID:26609485)

Biological Process: pathogenic process

Description: NA